Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 30, 2020ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)Open Access

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain.

Authors

Muthiah Vaduganathan
Muthiah VaduganathanHeart Failure / CardiomyopathyOVOrly VardenyHeart Failure / CardiomyopathyTMThomas MichelCross-Cutting Cardiology

Discussion

Loading...

Member takes

Implication

Effects of RAAS inhibitors on ACE2 remain uncertain in COVID-19; leaves open optimal management and need for targeted trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vaduganathan et al. (2020) studied this question.

synapsesocial.com/papers/69f7e54ea1b2dcd77ea6282ahttps://doi.org/10.1056/nejmsr2005760

Topics

Hypertension management
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory syndrome-coronavirus infections: A 4-year experience from a tertiary care center2019 · 38 citations
  2. 2Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension1996 · 234 citations
  3. 3Status of Hypertension in China2018 · 1,835 citations
  4. 4Angiotensin II AT<sub>1</sub> receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive rats2005 · 204 citations